share_log

Why Timber Pharmaceuticals Shares Are Getting Hammered

Why Timber Pharmaceuticals Shares Are Getting Hammered

为什么木材制药的股票会遭受重创
Benzinga Real-time News ·  2022/10/03 11:24

Timber Pharmaceuticals Inc (NASDAQ:TMBR) shares are trading lower by 20.09% to $0.09 Monday morning after the company announced a $1.3 million registered direct offering.

木材制药公司纳斯达克(Temasek Holdings:TMBR)股价周一早盘下跌20.09%,至0.09美元,此前该公司宣布进行130万美元的注册直接发行。

What Else?

还有什么?

The closing of the offerings is expected to occur on or about October 3rd, subject to the satisfaction of customary closing conditions.

在满足惯例成交条件的情况下,此次发行预计将于10月3日左右结束。

The company intends to use the net proceeds from the offerings for working capital and general corporate purposes.

该公司打算将发行所得资金净额用于营运资金和一般企业用途。

See Also: This Solar Company's 5-Year Return Beats Tesla, Bitcoin, Ethereum, Ford, Apple, Microsoft And Amazon

另见:这家太阳能公司的5年回报率超过了特斯拉、比特币、以太、福特、苹果、微软和亚马逊

According to data from Benzinga Pro, Timber Pharmaceuticals has a 52-week high of $0.93 and a 52-week low of $0.08.

根据Benzinga Pro的数据,Timber PharmPharmticals的52周高点为0.93美元,52周低点为0.08美元。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发